The Health Resources and Services Administration (HRSA) published a final notice on September 1, 2009 on how children’s hospitals that meet certain requirements may participate in the “340B” program, under which prescription drug manufacturers provide discounted drugs to certain eligible entities. The notice also informs discusses the obligation of manufacturers to provide the statutorily-mandated discount to those children’s hospitals. The notice is effective September 1, 2009.